P31324
PR
Gene name |
Prkar2b |
Protein name |
cAMP-dependent protein kinase type II-beta regulatory subunit |
Names |
|
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:19088 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
5 structures for P31324
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| 3TNP | X-ray | 230 A | B/E | 1-416 | PDB |
| 3TNQ | X-ray | 310 A | A | 1-416 | PDB |
| 4WBB | X-ray | 280 A | A | 1-416 | PDB |
| 4X6Q | X-ray | 252 A | B | 1-416 | PDB |
| AF-P31324-F1 | Predicted | AlphaFoldDB |
26 variants for P31324
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs29143009 | 69 | I>T | No | EVA | |
| rs3389234169 | 114 | C>* | No | EVA | |
| rs3389250097 | 135 | K>I | No | EVA | |
| rs3402935051 | 174 | K>N | No | EVA | |
| rs3403114845 | 174 | K>N | No | EVA | |
| rs3403137922 | 175 | E>* | No | EVA | |
| rs3403059710 | 175 | E>D | No | EVA | |
| rs3403194600 | 176 | G>V | No | EVA | |
| rs3403240890 | 177 | E>* | No | EVA | |
| rs3402734352 | 177 | E>D | No | EVA | |
| rs3403429358 | 177 | E>V | No | EVA | |
| rs3403194622 | 178 | H>P | No | EVA | |
| rs3402935055 | 179 | V>L | No | EVA | |
| rs3389210690 | 181 | D>Y | No | EVA | |
| rs3389235172 | 203 | C>S | No | EVA | |
| rs3389231138 | 214 | D>E | No | EVA | |
| rs3389245883 | 225 | M>I | No | EVA | |
| rs3389229015 | 231 | A>V | No | EVA | |
| rs3389244549 | 263 | K>M | No | EVA | |
| rs3389231155 | 271 | S>F | No | EVA | |
| rs3389210654 | 297 | D>V | No | EVA | |
| rs3403221977 | 344 | R>G | No | EVA | |
| rs3412902664 | 381 | R>S | No | EVA | |
| rs3389239568 | 382 | L>F | No | EVA | |
| rs3389237825 | 403 | A>P | No | EVA | |
| rs3403240946 | 405 | F>VPNSATNCSS* | No | EVA |
No associated diseases with P31324
3 regional properties for P31324
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Doublecortin domain | 12 - 100 | IPR003533-1 |
| domain | Doublecortin domain | 134 - 221 | IPR003533-2 |
| domain | Doublecortin domain-containing protein 2, doublecortin-like domain 2 | 138 - 217 | IPR033036 |
13 GO annotations of cellular component
| Name | Definition |
|---|---|
| cAMP-dependent protein kinase complex | An enzyme complex, composed of regulatory and catalytic subunits, that catalyzes protein phosphorylation. Inactive forms of the enzyme have two regulatory chains and two catalytic chains; activation by cAMP produces two active catalytic monomers and a regulatory dimer. |
| centrosome | A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle. |
| ciliary base | Area of the cilium (also called flagellum) where the basal body and the axoneme are anchored to the plasma membrane. The ciliary base encompasses the distal part of the basal body, transition fibers and transition zone and is structurally and functionally very distinct from the rest of the cilium. In this area proteins are sorted and filtered before entering the cilium, and many ciliary proteins localize specifically to this area. |
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| dendrite | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
| dendritic shaft | Cylindric portion of the dendrite, directly stemming from the perikaryon, and carrying the dendritic spines. |
| dendritic spine | A small, membranous protrusion from a dendrite that forms a postsynaptic compartment, typically receiving input from a single presynapse. They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable:they can be thin, stubby, mushroom, or branched, with a continuum of intermediate morphologies. They typically terminate in a bulb shape, linked to the dendritic shaft by a restriction. Spine remodeling is though to be involved in synaptic plasticity. |
| glutamatergic synapse | A synapse that uses glutamate as a neurotransmitter. |
| membrane raft | Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. |
| neuronal cell body | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
| perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| postsynapse | The part of a synapse that is part of the post-synaptic cell. |
7 GO annotations of molecular function
| Name | Definition |
|---|---|
| cAMP binding | Binding to cAMP, the nucleotide cyclic AMP (adenosine 3',5'-cyclophosphate). |
| cAMP-dependent protein kinase inhibitor activity | Binds to and stops, prevents or reduces the activity of a cAMP-dependent protein kinase. |
| cAMP-dependent protein kinase regulator activity | Modulation of the activity of the enzyme cAMP-dependent protein kinase. |
| protein domain specific binding | Binding to a specific domain of a protein. |
| protein kinase A catalytic subunit binding | Binding to one or both of the catalytic subunits of protein kinase A. |
| protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
| ubiquitin protein ligase binding | Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins. |
7 GO annotations of biological process
| Name | Definition |
|---|---|
| fatty acid metabolic process | The chemical reactions and pathways involving fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis. |
| learning | Any process in an organism in which a relatively long-lasting adaptive behavioral change occurs as the result of experience. |
| modulation of chemical synaptic transmission | Any process that modulates the frequency or amplitude of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse. Amplitude, in this case, refers to the change in postsynaptic membrane potential due to a single instance of synaptic transmission. |
| negative regulation of cAMP-dependent protein kinase activity | Any process that stops, prevents or reduces the frequency, rate or extent of cAMP-dependent protein kinase activity. |
| regulation of protein kinase activity | Any process that modulates the frequency, rate or extent of protein kinase activity. |
| response to antipsychotic drug | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antipsychotic drug stimulus. Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. |
| response to clozapine | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a clozapine stimulus. |
23 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| P07278 | BCY1 | cAMP-dependent protein kinase regulatory subunit | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) | SS |
| P00514 | PRKAR1A | cAMP-dependent protein kinase type I-alpha regulatory subunit | Bos taurus (Bovine) | EV |
| P00515 | PRKAR2A | cAMP-dependent protein kinase type II-alpha regulatory subunit | Bos taurus (Bovine) | EV |
| P31322 | PRKAR2B | cAMP-dependent protein kinase type II-beta regulatory subunit | Bos taurus (Bovine) | EV |
| Q5ZM91 | PRKAR1A | cAMP-dependent protein kinase type I-alpha regulatory subunit | Gallus gallus (Chicken) | SS |
| P16905 | Pka-R1 | cAMP-dependent protein kinase type I regulatory subunit | Drosophila melanogaster (Fruit fly) | PR |
| P81900 | Pka-R2 | cAMP-dependent protein kinase type II regulatory subunit | Drosophila melanogaster (Fruit fly) | PR |
| Q96M20 | CNBD2 | Cyclic nucleotide-binding domain-containing protein 2 | Homo sapiens (Human) | PR |
| P10644 | PRKAR1A | cAMP-dependent protein kinase type I-alpha regulatory subunit | Homo sapiens (Human) | EV |
| P13861 | PRKAR2A | cAMP-dependent protein kinase type II-alpha regulatory subunit | Homo sapiens (Human) | PR |
| P31321 | PRKAR1B | cAMP-dependent protein kinase type I-beta regulatory subunit | Homo sapiens (Human) | EV |
| P31323 | PRKAR2B | cAMP-dependent protein kinase type II-beta regulatory subunit | Homo sapiens (Human) | PR |
| Q9D5U8 | Cnbd2 | Cyclic nucleotide-binding domain-containing protein 2 | Mus musculus (Mouse) | PR |
| P12849 | Prkar1b | cAMP-dependent protein kinase type I-beta regulatory subunit | Mus musculus (Mouse) | PR |
| Q9DBC7 | Prkar1a | cAMP-dependent protein kinase type I-alpha regulatory subunit [Cleaved into: cAMP-dependent protein kinase type I-alpha regulatory subunit, N-terminally processed] | Mus musculus (Mouse) | SS |
| P12367 | Prkar2a | cAMP-dependent protein kinase type II-alpha regulatory subunit | Mus musculus (Mouse) | PR |
| P05207 | PRKAR2A | cAMP-dependent protein kinase type II-alpha regulatory subunit | Sus scrofa (Pig) | SS |
| P07802 | PRKAR1A | cAMP-dependent protein kinase type I-alpha regulatory subunit | Sus scrofa (Pig) | SS |
| P81377 | Prkar1b | cAMP-dependent protein kinase type I-beta regulatory subunit | Rattus norvegicus (Rat) | PR |
| P09456 | Prkar1a | cAMP-dependent protein kinase type I-alpha regulatory subunit | Rattus norvegicus (Rat) | SS |
| P12368 | Prkar2a | cAMP-dependent protein kinase type II-alpha regulatory subunit | Rattus norvegicus (Rat) | PR |
| P12369 | Prkar2b | cAMP-dependent protein kinase type II-beta regulatory subunit | Rattus norvegicus (Rat) | PR |
| P30625 | kin-2 | cAMP-dependent protein kinase regulatory subunit | Caenorhabditis elegans | SS |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MSIEIPAGLT | ELLQGFTVEV | LRHQPADLLE | FALQHFTRLQ | QENERKGAAR | FGHEGRTWGD |
| 70 | 80 | 90 | 100 | 110 | 120 |
| AGAAAGGGIP | SKGVNFAEEP | MRSDSENGEE | EEAAEAGAFN | APVINRFTRR | ASVCAEAYNP |
| 130 | 140 | 150 | 160 | 170 | 180 |
| DEEEDDAESR | IIHPKTDDQR | NRLQEACKDI | LLFKNLDPEQ | MSQVLDAMFE | KLVKEGEHVI |
| 190 | 200 | 210 | 220 | 230 | 240 |
| DQGDDGDNFY | VIDRGTFDIY | VKCDGVGRCV | GNYDNRGSFG | ELALMYNTPR | AATITATSPG |
| 250 | 260 | 270 | 280 | 290 | 300 |
| ALWGLDRVTF | RRIIVKNNAK | KRKMYESFIE | SLPFLKSLEV | SERLKVVDVI | GTKVYNDGEQ |
| 310 | 320 | 330 | 340 | 350 | 360 |
| IIAQGDLADS | FFIVESGEVK | ITMKRKGKSE | VEENGAVEIA | RCFRGQYFGE | LALVTNKPRA |
| 370 | 380 | 390 | 400 | 410 | |
| ASAHAIGTVK | CLAMDVQAFE | RLLGPCMEIM | KRNIATYEEQ | LVALFGTNMD | IVEPTA |